Faron Pharmaceuticals - Innovative medical solutions (Part 2)

Of the censored ones, 6 proceeded to bone marrow transplant, so 9 were censored for some other reason. And at around the 1200-day mark, even the last patient was censored. (I wonder if that is the data readout moment 11/2025?)
Follow-up seems to have ended in death for 17 patients (of which 6 were non-TP53 and 11 were TP35).
If there are errors here, feel free to correct them.

3 Likes